• Facebook
  • X
  • Instagram
MYELOMA360
  • Home
  • MYBoard
  • MYInsights
  • Strategy & Consulting
  • Contact Us
Select Page

10 Multiple Myeloma Questions and Answers: Treatments and Side Effects

by | Aug 29, 2024 | Uncategorized

Source: CureToday articles Patients with multiple myeloma now have several available treatment options, so it’s important to have answers to some of the frequently asked questions. Read More

The Solitude of Reality With Multiple Myeloma

by | Aug 28, 2024 | Uncategorized

Source: CureToday articles I was diagnosed with stage 1 multiple myeloma in 2018 and writing poetry helped me work through feelings of anger and acceptance. Read More

Multiple Myeloma: 8 Frequently Asked Patient Questions

by | Aug 27, 2024 | Uncategorized

Source: CureToday articles Questions about multiple myeloma regarding treatment options, bone strength and other associated comorbidities were answered by an expert. Read More

My Olympics With Multiple Myeloma

by | Aug 12, 2024 | Uncategorized

Source: CureToday articles After my myeloma diagnosis, each day is my own personal Olympics, filled with trials and triumph. Read More

FDA Approves Darzalex Faspro Regimen for Some With Multiple Myeloma

by | Jul 30, 2024 | Uncategorized

Source: CureToday articles The FDA approved Darzalex Faspro with Velcade, Revlimid and dexamethasone for select patients newly diagnosed with multiple myeloma. Read More

Myeloma-Related Questions to Ask After Diagnosis

by | Jul 29, 2024 | Uncategorized

Source: CureToday articles From finding reputable info to asking, “Do I really need all these drugs?” experts weighed in on important questions to ask after a myeloma diagnosis. Read More
« Older Entries
Next Entries »

Recent Content

  • FDA OKs Investigational New Drug Application for VS-7375 in Solid Tumors
  • Hydroxyurea Produces Long-Term Clinical Benefits in Pediatrics With Sickle Cell Anemia
  • Crafting an Individual Treatment Plan for Patients With Prostate Cancer
  • DPYD Testing Gains Ground: NCCN Guideline Update Reflects Decades of Work Toward Safer Chemotherapy
  • NCCN Flash Update: Changes to Colon Cancer Guidelines, Version 3.2025
  • Commitment to Patients Is Driven by a Lasting Promise
  • AAN 2025: Low-Sodium Oxybate Improves Sleep Quality, Daily Functioning in Narcolepsy, Idiopathic Hypersomnia
  • Understanding the FDA Imfinzi Combo Approval for Bladder Cancer Care
  • New Options for ER+ Breast Cancer Spotlighted at Patient Event
  • Asembia’s AXS25 Summit: Must-See Sessions, Expert Interviews as Specialty Pharmacy Gathers
  • Facebook
  • X
  • Instagram
©2016-2025 MYELOMA360 & Connect BioMed
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.
SettingsAccept
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT